GABA-glutamate Interactions and Psychosis

Diseases and Conditions Researched

Cognitive Dysfunction

What is the purpose of this trial?

This study investigates the interactions between NMDA (N-Methyl-D-aspartic acid) antagonism and GABA (gamma-aminobutyric acid) system as it relates to cognitive function assessed by ERPs (event-related potentials) in healthy volunteers.



Participation Guidelines

Age: 21 Years - 45 Years
Gender: Both

This trial accepts healthy volunteers.

Click here for detailed participation information for this trial.

Sponsors: National Alliance for Research on Schizophrenia and Depression; Yale University
Dates: January 29, 2008
Last Updated: May 17, 2012
Study HIC#: 0508000517
Clinicaltrials.gov ID: NCT00611572